在人类hRAS基因中单核酸多态的计算探索:含义和见解
Sankar Dakshitha1, Boopathi Priya Dharshini1, Vasugi Suresh1
1Physiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.
Cureus
|February 29, 2024
概括
这项研究分析了人类哈维大鼠肉瘤病毒 (hRAS) 基因中的单核酸多态 (SNP). 在11个确定的SNP中,有9个是有害的,表明潜在的癌症诊断标志物.
科学领域:
- 遗传学和分子生物学
- 生物信息学是一种生物信息学.
- 癌症研究 癌症研究
背景情况:
- 哈维大鼠肉瘤病毒 (hRAS) 基因是一种参与细胞分裂和信号转导的瘤基因.
- 包括hRAS,kRAS和nRAS在内的RAS家族瘤基因编码调节细胞过程的Rho GTPases.
- 在hRAS中错误的单核酸多态 (SNPs) 可以改变蛋白质结构和功能,可能导致癌症.
研究的目的:
- 预测人类hRAS基因中误解单核酸多态 (SNPs) 的结构和稳定性影响.
- 在hRAS中使用生物信息工具识别潜在的有害SNP.
- 评估hRAS SNPs作为癌症诊断标记物的潜力.
主要方法:
- 使用尺度不变特征转换 (SIFT) 的生物信息分析,通过进化关系进行蛋白质分析 (PANTHER),PROVEAN和SNAP.
- 预测hRAS中的误解SNP的功能意义和破坏潜力.
- 将SNP分类为有害的,可以容忍的,可能有害的或可能无害的.
主要成果:
- 在hRAS基因中使用SIFT识别了11个具有功能意义的SNP.
- 在11个分析的SNP中,有9个预测是有害的.
- PANTHER分析将七种SNP归类为可能有害的 (高风险),四种可能是良性的.
结论:
- 在hRAS基因中的误解SNP可能会产生显著的功能后果.
- 已识别的高风险SNP是癌症相关细胞变化的潜在候选者.
- hRAS SNPs可以作为癌症检测的有价值的诊断标记.
更多相关视频
07:17Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
Published on: August 23, 2024
1.1K
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
11.8K
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Homologous Recombination
50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
